Applying the healing properties of progenitor cell therapies to alleviate and heal a range of medical conditions – starting with dermatology and gynecology.
Elanix develops and markets progenitor cell-based products to help regenerate tissue and promote healing in the treatment of burns, and gynecological and dermatological conditions. The Company is headquartered in Nyon, Canton Vaud, Switzerland, with offices in Potsdam, Germany, and listed on the Frankfurt stock exchange under the symbol ELN.
Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix enhances the activity of progenitor cells with proprietary cytokine formulations to create unique cell therapy products and procedures.
Our pipeline of progenitor cell products combines a development-stage, advanced biological bandage that promotes skin healing in deep burn victims and two enhanced OTC creams. GynRepair® is used by our customers to (sold in Switzerland since 2011) alleviate the symptoms of vulvodynia, a fairly common women’s health issue. RepAir-A® is a dermatological used to rejuvenate the skin following damage, e.g. from sun exposure or late-stage healing process after deep burns.
Financial information and stock performance data can be found in the Investor Relations sections in both English and German
VETERANS NATIONAL RECOVERY CENTER READY TO GO ON HOT SPRINGS RE-USE ALTERNATIVE
Bob Krause, President of the Veterans Nat [...]view article
Elanix Biotechnologies AG announces non-binding letter of intent with Oxford MEStar Ltd. in regard to setting up a JV to market GynRepair in China
Potsdam, November 22, 2016 – Elanix Biote [...]view article
ELANIX BIOTECHNOLOGIES AG STRATEGIC PARTNER, TRANSWELL BIOTECHNOLOGY LTD., RECEIVES US FDA CLEARANCE FOR PHASE I/II CLINICAL TRIAL USING FIBROBLAST PROGENITORS TWB-103
Nyon, Switzerland and Potsdam, Germ [...]view article
ELANIX BIOTECHNOLOGIES AG, KEY PATENT FOR THE PREPARATION OF PARENTAL CELL BANK GRANTED IN THE U.S.A.
Nyon, Switzerland and Potsdam, Germany, [...]view article